Literature DB >> 11129105

Comparative effects of repeated administration of dopamine agonists on circling behavior in rats.

A Prikhojan1, T Brannan, M D Yahr.   

Abstract

A paucity of studies are available concerning the comparative therapeutic effectiveness of presently available dopamine agonist agents in the control of Parkinson symptoms. To provide a basis for resolving this issue, we measured the circling response in unilaterally nigrotomized (6-OHDA) rats following the administration of ropinirole, pramipexole, pergolide, bromocriptine, and cabergoline. Cabergoline, and to a lesser extent pergolide, produced the most vigorous and longest lasting circling response. This response was sustained with administration of these agents over a nine day period. Bromocriptine, pramipexole and ropinirole were all less effective. These results suggest that dopamine agonists whose effect is primarily on D1 and D2 receptors are more effective than those whose actions do not include D1 activation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11129105     DOI: 10.1007/s007020070029

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  5 in total

1.  D1 Antagonists and D2 Agonists Have Opposite Effects on the Metabolism of Dopamine in the Rat Striatum.

Authors:  Alberto Avila-Luna; Jacqueline Prieto-Leyva; Arturo Gálvez-Rosas; Alfonso Alfaro-Rodriguez; Rigoberto Gonzalez-Pina; Antonio Bueno-Nava
Journal:  Neurochem Res       Date:  2015-05-17       Impact factor: 3.996

2.  Increased motor impulsivity in a rat gambling task during chronic ropinirole treatment: potentiation by win-paired audiovisual cues.

Authors:  Melanie Tremblay; Michael M Barrus; Paul J Cocker; Christelle Baunez; Catharine A Winstanley
Journal:  Psychopharmacology (Berl)       Date:  2019-01-31       Impact factor: 4.530

3.  Effects of noradrenergic denervation by anti-DBH-saporin on behavioral responsivity to L-DOPA in the hemi-parkinsonian rat.

Authors:  Corinne Y Ostock; David Lindenbach; Adam A Goldenberg; Elias Kampton; Christopher Bishop
Journal:  Behav Brain Res       Date:  2014-05-13       Impact factor: 3.332

Review 4.  Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease.

Authors:  Susan Duty; Peter Jenner
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

Review 5.  Unraveling protein misfolding diseases using model systems.

Authors:  Sara Peffer; Kimberly Cope; Kevin A Morano
Journal:  Future Sci OA       Date:  2015-09-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.